Skip to content
OpenCapital
Get started

Cardinal Health CAH Shares (Diluted)

Shares (Diluted) at other companies

Eli Lilly logo
Eli LillyLLY
895.9M-0.5%
Alpha Pro Tech logo
Alpha Pro TechAPT
10.6M-6.1%
McKesson logo
McKessonMCK
124.1M-3.1%
Cencora logo
CencoraCOR
195.4M+0.1%
AbbVie logo
AbbVieABBV
1.8B+0.1%
Avanos Medical logo
Avanos MedicalAVNS
47.5M+1.5%

Other financials

Income statement

See full
Revenue$60.9B+11.0%
Gross profit$2.5B+17.7%
Operating income$509.0M-30.3%
Net income$399.0M-21.1%
EPS (diluted)$1.69-19.5%

Balance sheet

See full
Cash & equivalents$3.9B+18.4%
Total debt$8.9B+16.1%
Total equity-$2.8B+3.9%
Total assets$56.7B+13.7%

Cash flow

See full
Operating cash flow$1.8B-37.6%
CapEx$146.0M+15.9%
Free cash flow$1.7B-40.0%

Valuation

See full
Market cap$55.64B+40.8%
Enterprise value$60.62B+34.1%
P/E35.8×+10.5×
P/S0.2×0.0×

Profitability

See full
Gross margin3.8%+0.2pp
Operating margin0.9%-0.1pp
Net margin0.6%-0.1pp
FCF margin1.7%+0.6pp

Returns & leverage

See full
Return on equity37.4%—
Debt / equity4.1×—
Current ratio0.9×0.0×

Where this comes from

Reported directly by Cardinal Health in its filing.

Tagged under the XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding.

The official record: Cardinal Health’s 10-Q, filed April 30, 2026, on SEC EDGAR. View the filing →

Ask your AI about Cardinal Health's shares (diluted).

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Cardinal Health's shares (diluted)?
Cardinal Health (CAH) reported shares (diluted) of 236M in Q1 2026.
How has Cardinal Health's shares (diluted) changed year-over-year?
Cardinal Health's shares (diluted) decreased by 2.1% year-over-year, from 241M to 236M.
What is the long-term trend for Cardinal Health's shares (diluted)?
Over 3 years (2022 to 2025), Cardinal Health's shares (diluted) has grown at a -4.8% compound annual growth rate (CAGR), from 1.1B to 971M.
What does shares (diluted) mean?
The weighted-average shares outstanding plus all potentially dilutive shares from stock options, RSUs, convertible securities, and warrants, using the treasury stock method.